{
    "2020-05-25": [
        [
            {
                "time": "",
                "original_text": "凯莱英：两位副总经理合计减持2.93万股 减持股份",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "副总经理",
                        "减持",
                        "2.93万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "进展！凯莱英：部分高管减持公司股份约2.93万股 减持股份",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "高管",
                        "减持",
                        "2.93万股"
                    ],
                    "sentiment_score": -0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "凯莱英(002821.SZ)：2名高管已合计减持2.93万股 减持股份",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "高管",
                        "减持",
                        "2.93万股",
                        "002821.SZ"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "生物医药行业周报：第三批带量采购即将开展 仿制药集采进入常态",
                "features": {
                    "keywords": [
                        "生物医药",
                        "带量采购",
                        "仿制药",
                        "集采",
                        "常态化"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "仿制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}